Pharmaceutical trade association Medicines Australia says it welcomes the release of Research Australia's report into medical advances, titled "Then, Now...Imagine," which was developed in consultation with 10 of Australia's leading health and medical researchers to predict what the future holds for major developments in research. The report highlights the importance of medical research in Australia, giving examples of past Australian achievements and predictions for the future.
"The recent high-profile success of Australian science, whether it is winning the Nobel Prize for Medicine or discovering the world's first ever cancer vaccine, demonstrates the value of investing in medical research and encouraging careers in science and technology," said Medicines Australia chief executive Ian Chalmers. "The benefits of investing in health and medical research are leading to real benefits for Australian patients and it is important that Australians can continue to access innovative new medicines into the future through the Pharmaceutical Benefits Scheme," he added.
In the report, top Australian scientists predict that individual gene profiling from blood samples will revolutionize health care within 10 years, "smart drugs" will be used to target cancer at the source as a result of DNA technology and viruses will be found to play a role in many other cancers and, in the course of the next few decades, there will be a raft of new vaccines to prevent their onset.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze